-
1
-
-
0003476675
-
Carnitine and carnitine esters in mitochondial metabolism and function
-
DeJong J., and Ferrari R. (Eds), Kluwer Academic Publishers, Norwell, Massachusetts
-
DiLisa F., Barbato R., Menabò R., et al. Carnitine and carnitine esters in mitochondial metabolism and function. In: DeJong J., and Ferrari R. (Eds). The Carnitine System (2005), Kluwer Academic Publishers, Norwell, Massachusetts 21-38
-
(2005)
The Carnitine System
, pp. 21-38
-
-
DiLisa, F.1
Barbato, R.2
Menabò, R.3
-
3
-
-
77953285722
-
Carnitine in renal failure
-
Kopple J., and Massry S. (Eds), Lippincott Williams & Wilkins, Baltimore, Maryland
-
Guarnieri G., Biolo G., Toigo G., et al. Carnitine in renal failure. In: Kopple J., and Massry S. (Eds). Nutritional Management of Renal Disease (2001), Lippincott Williams & Wilkins, Baltimore, Maryland 357-368
-
(2001)
Nutritional Management of Renal Disease
, pp. 357-368
-
-
Guarnieri, G.1
Biolo, G.2
Toigo, G.3
-
4
-
-
4444311812
-
Carnitine acyltransferases and their influence on CoA pools in health and disease
-
Ramsay R.R., and Zammit V.A. Carnitine acyltransferases and their influence on CoA pools in health and disease. Mol Aspects Med 25 (2004) 475-493
-
(2004)
Mol Aspects Med
, vol.25
, pp. 475-493
-
-
Ramsay, R.R.1
Zammit, V.A.2
-
5
-
-
10644253401
-
The role of the carnitine system in human metabolism
-
Foster D.W. The role of the carnitine system in human metabolism. Ann N Y Acad Sci 1033 (2004) 1-16
-
(2004)
Ann N Y Acad Sci
, vol.1033
, pp. 1-16
-
-
Foster, D.W.1
-
6
-
-
4444315751
-
Carnitine: A nutritional, biosynthetic, and functional perspective
-
Steiber A., Kerner J., and Hoppel C.L. Carnitine: A nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25 (2004) 455-473
-
(2004)
Mol Aspects Med
, vol.25
, pp. 455-473
-
-
Steiber, A.1
Kerner, J.2
Hoppel, C.L.3
-
7
-
-
27744549045
-
Levocarnitine and dialysis: A review
-
Schreiber B. Levocarnitine and dialysis: A review. Nutr Clin Practice 20 (2005) 218-243
-
(2005)
Nutr Clin Practice
, vol.20
, pp. 218-243
-
-
Schreiber, B.1
-
8
-
-
23244446985
-
L-carnitine: New aspects of a known compound-A brief survey
-
Lohninger A., Pittner G., and Pittner F. L-carnitine: New aspects of a known compound-A brief survey. Monatshefte Chemie 136 (2005) 1255-1368
-
(2005)
Monatshefte Chemie
, vol.136
, pp. 1255-1368
-
-
Lohninger, A.1
Pittner, G.2
Pittner, F.3
-
9
-
-
23244441419
-
The role of carnitine acyltransferases in the maintenance of cell function
-
Zammit V.A., Price N.T., Jackson V.N., et al. The role of carnitine acyltransferases in the maintenance of cell function. Monatshefte Chemie 136 (2005) 1299-1309
-
(2005)
Monatshefte Chemie
, vol.136
, pp. 1299-1309
-
-
Zammit, V.A.1
Price, N.T.2
Jackson, V.N.3
-
10
-
-
0023626878
-
Carnitine metabolism in chronic renal failure
-
Guarnieri G., Toigo G., Crapesi L., et al. Carnitine metabolism in chronic renal failure. Kidney Int 32 (1987) S116-S127
-
(1987)
Kidney Int
, vol.32
-
-
Guarnieri, G.1
Toigo, G.2
Crapesi, L.3
-
11
-
-
0024824287
-
Metabolic effects of supplementation of L-carnitine in the dialysate of patients treated with acetate hemodialysis
-
Guarnieri G., Toigo G., Crapesi L., et al. Metabolic effects of supplementation of L-carnitine in the dialysate of patients treated with acetate hemodialysis. Kidney Int 36 (1989) S247-S255
-
(1989)
Kidney Int
, vol.36
-
-
Guarnieri, G.1
Toigo, G.2
Crapesi, L.3
-
12
-
-
0002902876
-
L-carnitine administration to hemodialysis patients: Has its time come?
-
Golper T.A., and Ahmad S. L-carnitine administration to hemodialysis patients: Has its time come?. Semin Dial 5 (1992) 94-98
-
(1992)
Semin Dial
, vol.5
, pp. 94-98
-
-
Golper, T.A.1
Ahmad, S.2
-
13
-
-
0033830243
-
Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis
-
Evans A.M., Faull R., Fornasini G., et al. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 68 (2000) 238-249
-
(2000)
Clin Pharmacol Ther
, vol.68
, pp. 238-249
-
-
Evans, A.M.1
Faull, R.2
Fornasini, G.3
-
14
-
-
4644278071
-
Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease
-
Evans A.M., Faull R.J., Nation R.L., et al. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney Int 66 (2004) 1527-1534
-
(2004)
Kidney Int
, vol.66
, pp. 1527-1534
-
-
Evans, A.M.1
Faull, R.J.2
Nation, R.L.3
-
15
-
-
25144483298
-
Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease
-
Reuter S.E., Evans A.M., Faull R.J., et al. Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease. Ann Clin Biochem 42 (2005) 387-393
-
(2005)
Ann Clin Biochem
, vol.42
, pp. 387-393
-
-
Reuter, S.E.1
Evans, A.M.2
Faull, R.J.3
-
16
-
-
10644293209
-
Carnitine replacement in end-stage renal disease and hemodialysis
-
Calvani M., Benatti P., Mancinelli A., et al. Carnitine replacement in end-stage renal disease and hemodialysis. Ann N Y Acad Sci 1033 (2004) 52-66
-
(2004)
Ann N Y Acad Sci
, vol.1033
, pp. 52-66
-
-
Calvani, M.1
Benatti, P.2
Mancinelli, A.3
-
17
-
-
0036192012
-
Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review
-
Hurot J.M., Cucherat M., Haugh M., et al. Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review. J Am Soc Nephrol 13 (2002) 708-714
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 708-714
-
-
Hurot, J.M.1
Cucherat, M.2
Haugh, M.3
-
19
-
-
0035011124
-
Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients
-
Brass E.P., Adler S., Sietsema K.E., et al. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis 37 (2001) 1018-1028
-
(2001)
Am J Kidney Dis
, vol.37
, pp. 1018-1028
-
-
Brass, E.P.1
Adler, S.2
Sietsema, K.E.3
-
20
-
-
0025152162
-
Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects
-
Ahmad S., Robertson H.T., Golper T.A., et al. Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kideny Int 38 (1990) 912-918
-
(1990)
Kideny Int
, vol.38
, pp. 912-918
-
-
Ahmad, S.1
Robertson, H.T.2
Golper, T.A.3
-
21
-
-
0024268248
-
Interaction of carnitine with insulin-stimulated glucose metabolism in humans
-
Ferrannini E., Buzzigoli G., Bevilacqua S., et al. Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 255 (1988) E946-E952
-
(1988)
Am J Physiol
, vol.255
-
-
Ferrannini, E.1
Buzzigoli, G.2
Bevilacqua, S.3
-
22
-
-
2442766181
-
The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure
-
Gunal A.I., Celiker H., Donder E., et al. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure. J Nephrol 12 (1999) 38-40
-
(1999)
J Nephrol
, vol.12
, pp. 38-40
-
-
Gunal, A.I.1
Celiker, H.2
Donder, E.3
-
23
-
-
0036788293
-
Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes
-
Kelley D.E., He J., Menshikova E.V., et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 (2002) 2944-2950
-
(2002)
Diabetes
, vol.51
, pp. 2944-2950
-
-
Kelley, D.E.1
He, J.2
Menshikova, E.V.3
-
25
-
-
0023835418
-
Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle
-
Smogorzewski M., Piskorska G., Borum P.R., et al. Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle. Kidney Int 33 (1988) 555-560
-
(1988)
Kidney Int
, vol.33
, pp. 555-560
-
-
Smogorzewski, M.1
Piskorska, G.2
Borum, P.R.3
-
26
-
-
11844251989
-
Inflammation and carnitine in hemodialysis patients
-
Pertosa G., Grandaliano G., Simone S., et al. Inflammation and carnitine in hemodialysis patients. J Ren Nutr 15 (2005) 8-12
-
(2005)
J Ren Nutr
, vol.15
, pp. 8-12
-
-
Pertosa, G.1
Grandaliano, G.2
Simone, S.3
-
27
-
-
11844262893
-
L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients
-
Savica V., Santoro D., Mazzaglia G., et al. L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients. J Ren Nutr 15 (2005) 225-230
-
(2005)
J Ren Nutr
, vol.15
, pp. 225-230
-
-
Savica, V.1
Santoro, D.2
Mazzaglia, G.3
-
28
-
-
10644296222
-
Carnitines and its congeners: A metabolic pathway to the regulation of immune response and inflammation
-
Famularo G., DeSimone C., Trinchieri V., et al. Carnitines and its congeners: A metabolic pathway to the regulation of immune response and inflammation. Ann N Y Acad Sci 1033 (2004) 132-138
-
(2004)
Ann N Y Acad Sci
, vol.1033
, pp. 132-138
-
-
Famularo, G.1
DeSimone, C.2
Trinchieri, V.3
-
29
-
-
0027405265
-
High dose L-carnitine improves immunologic and metabolic parameters in AIDS patients
-
DeSimone C., Tzantzoglu S., Famularo G., et al. High dose L-carnitine improves immunologic and metabolic parameters in AIDS patients. Immunopharmacol Immunotoxicol 15 (1993) 1-12
-
(1993)
Immunopharmacol Immunotoxicol
, vol.15
, pp. 1-12
-
-
DeSimone, C.1
Tzantzoglu, S.2
Famularo, G.3
-
30
-
-
0030028606
-
The expression of TNF alpha by human muscle: Relationship to insulin resistance
-
Saghizadeh M., Ong J.M., Garvey W.T., et al. The expression of TNF alpha by human muscle: Relationship to insulin resistance. J Clin Invest 97 (1996) 1111-1116
-
(1996)
J Clin Invest
, vol.97
, pp. 1111-1116
-
-
Saghizadeh, M.1
Ong, J.M.2
Garvey, W.T.3
-
31
-
-
23244468294
-
Carnitine and fatty acid oxidation in sepsis
-
Eaton S., and Pierro A. Carnitine and fatty acid oxidation in sepsis. Monats Chemie 136 (2005) 1483-1492
-
(2005)
Monats Chemie
, vol.136
, pp. 1483-1492
-
-
Eaton, S.1
Pierro, A.2
-
32
-
-
0041703026
-
L-carnitine: A nutritional modulator of glucocorticoid receptor functions
-
Alesci S., DeMartino M.U., Mirani M., et al. L-carnitine: A nutritional modulator of glucocorticoid receptor functions. FASEB J 17 (2003) 1553-1555
-
(2003)
FASEB J
, vol.17
, pp. 1553-1555
-
-
Alesci, S.1
DeMartino, M.U.2
Mirani, M.3
-
33
-
-
10644296911
-
Modulatory effects of L-carnitine on glucocorticoid receptor activity
-
Manoli I., De Martino M.U., Kino T., et al. Modulatory effects of L-carnitine on glucocorticoid receptor activity. Ann N Y Acad Sci 1033 (2004) 147-157
-
(2004)
Ann N Y Acad Sci
, vol.1033
, pp. 147-157
-
-
Manoli, I.1
De Martino, M.U.2
Kino, T.3
-
34
-
-
0028887004
-
Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock
-
Winter B.K., Fiskum G., Gallo L.L., et al. Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br J Cancer 72 (1995) 1173-1179
-
(1995)
Br J Cancer
, vol.72
, pp. 1173-1179
-
-
Winter, B.K.1
Fiskum, G.2
Gallo, L.L.3
-
35
-
-
0034936833
-
Effect of L-carnitine supplementation in hemodialysis patients
-
Vesela E., Racek J., Trefil L., et al. Effect of L-carnitine supplementation in hemodialysis patients. Nephron 88 (2001) 218-223
-
(2001)
Nephron
, vol.88
, pp. 218-223
-
-
Vesela, E.1
Racek, J.2
Trefil, L.3
-
36
-
-
0037219409
-
Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?
-
Evans J.L., Goldfine I.D., Maddux B.A., et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes 52 (2003) 1-8
-
(2003)
Diabetes
, vol.52
, pp. 1-8
-
-
Evans, J.L.1
Goldfine, I.D.2
Maddux, B.A.3
-
37
-
-
0037225664
-
Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress
-
Pignatelli P., Lenti L., Sanguigni V., et al. Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress. Am J Physiol Heart Circ Physiol 284 (2003) H41-H48
-
(2003)
Am J Physiol Heart Circ Physiol
, vol.284
-
-
Pignatelli, P.1
Lenti, L.2
Sanguigni, V.3
-
38
-
-
2042460866
-
L-carnitine ameliorates oxidative damage due to chronic renal failure in rats
-
Sener G., Paskaloglu K., Satiroglu H., et al. L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol 43 (2004) 698-705
-
(2004)
J Cardiovasc Pharmacol
, vol.43
, pp. 698-705
-
-
Sener, G.1
Paskaloglu, K.2
Satiroglu, H.3
-
39
-
-
28844438030
-
Antioxidant effect of L-carnitine and its short chain esters: Relevance for the protection from oxidative stress related cardiovascular damage
-
Calò L.A., Pagnin E., Davis P.A., et al. Antioxidant effect of L-carnitine and its short chain esters: Relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol 107 (2006) 54-60
-
(2006)
Int J Cardiol
, vol.107
, pp. 54-60
-
-
Calò, L.A.1
Pagnin, E.2
Davis, P.A.3
-
40
-
-
0031764132
-
Body composition and long-term levo-carnitine supplementation
-
Trovato G.M., Iannetti E., Murgo A.M., et al. Body composition and long-term levo-carnitine supplementation. Clin Ter 149 (1998) 209-214
-
(1998)
Clin Ter
, vol.149
, pp. 209-214
-
-
Trovato, G.M.1
Iannetti, E.2
Murgo, A.M.3
-
41
-
-
0035752994
-
Dietary L-carnitine suppresses mitochondrial branched-chain keto acid dehydrogenase activity and enhances protein accretion and carcass characteristics of swine
-
Owen K.Q., Jit H., Maxwell C.V., et al. Dietary L-carnitine suppresses mitochondrial branched-chain keto acid dehydrogenase activity and enhances protein accretion and carcass characteristics of swine. J Anim Sci 79 (2001) 3104-3112
-
(2001)
J Anim Sci
, vol.79
, pp. 3104-3112
-
-
Owen, K.Q.1
Jit, H.2
Maxwell, C.V.3
-
42
-
-
9344242965
-
Atlantic salmon (Salmo salar) fed L-carnitine exhibit altered intermediary metabolism and reduced tissue lipid, but no change in growth rate
-
Ji H., Bradley T.M., and Tremblay G.C. Atlantic salmon (Salmo salar) fed L-carnitine exhibit altered intermediary metabolism and reduced tissue lipid, but no change in growth rate. J Nutr 126 (1996) 1937-1950
-
(1996)
J Nutr
, vol.126
, pp. 1937-1950
-
-
Ji, H.1
Bradley, T.M.2
Tremblay, G.C.3
-
43
-
-
4944239832
-
Cancer-related anorexia-cachexia syndrome and oxidative stress: An innovative approach beyond current treatment
-
Mantovani G., Madeddu C., Maccio A., et al. Cancer-related anorexia-cachexia syndrome and oxidative stress: An innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev 13 (2004) 1651-1659
-
(2004)
Cancer Epidemiol Biomarkers Prev
, vol.13
, pp. 1651-1659
-
-
Mantovani, G.1
Madeddu, C.2
Maccio, A.3
-
44
-
-
0028153264
-
Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers
-
Giovenali P., Fenocchio D., Montanari G., et al. Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Kidney Int 46 (1994) 1616-1619
-
(1994)
Kidney Int
, vol.46
, pp. 1616-1619
-
-
Giovenali, P.1
Fenocchio, D.2
Montanari, G.3
-
45
-
-
0025152162
-
Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects
-
Ahmad S., Robertson H.T., Golper T.A., et al. Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38 (1990) 912-918
-
(1990)
Kidney Int
, vol.38
, pp. 912-918
-
-
Ahmad, S.1
Robertson, H.T.2
Golper, T.A.3
-
46
-
-
0022887274
-
Effect of L-carnitine on post-stress metabolism in surgical patients
-
Heller W., Musil H.E., Gaebel G., et al. Effect of L-carnitine on post-stress metabolism in surgical patients. Infusionsther Klin Ernahr 13 (1986) 268-276
-
(1986)
Infusionsther Klin Ernahr
, vol.13
, pp. 268-276
-
-
Heller, W.1
Musil, H.E.2
Gaebel, G.3
-
47
-
-
0024593903
-
Clinical relevance of L-carnitine-supplemented total parenteral nutrition in postoperative trauma: Metabolic effects of continuous or acute carnitine administration with special reference to fat oxidation and nitrogen utilization
-
Pichard C., Roulet M., Schutz Y., et al. Clinical relevance of L-carnitine-supplemented total parenteral nutrition in postoperative trauma: Metabolic effects of continuous or acute carnitine administration with special reference to fat oxidation and nitrogen utilization. Am J Clin Nutr 49 (1989) 283-289
-
(1989)
Am J Clin Nutr
, vol.49
, pp. 283-289
-
-
Pichard, C.1
Roulet, M.2
Schutz, Y.3
-
48
-
-
3342936592
-
The effect of L-carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects
-
Wutzke K.D., and Lorenz H. The effect of L-carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects. Metabolism 53 (2004) 1002-1006
-
(2004)
Metabolism
, vol.53
, pp. 1002-1006
-
-
Wutzke, K.D.1
Lorenz, H.2
-
49
-
-
33845729499
-
-
Merida, Mexico, XIII International Congress on Nutrition and Metabolism in Renal Disease
-
Biolo G., Stulle M., Piccoli A., et al. Carnitine depletion impairs the protein anabolic response to insulin in hemodialysis patients (2006) 41 Merida, Mexico, XIII International Congress on Nutrition and Metabolism in Renal Disease
-
(2006)
Carnitine depletion impairs the protein anabolic response to insulin in hemodialysis patients
, pp. 41
-
-
Biolo, G.1
Stulle, M.2
Piccoli, A.3
-
50
-
-
0028850504
-
Primary and secondary carnitine deficiency syndromes
-
Pons R., and DeVivo D.C. Primary and secondary carnitine deficiency syndromes. J Child Neurol 10 suppl 2 (1995) S8-S24
-
(1995)
J Child Neurol
, vol.10
, Issue.SUPPL. 2
-
-
Pons, R.1
DeVivo, D.C.2
-
51
-
-
20844457939
-
Carnitine therapy is associated with decreased hospital utilization among hemodialysis patients
-
Kazmi W.H., Obrador G.T., Sternberg M., et al. Carnitine therapy is associated with decreased hospital utilization among hemodialysis patients. Am J Nephrol 25 (2005) 106-115
-
(2005)
Am J Nephrol
, vol.25
, pp. 106-115
-
-
Kazmi, W.H.1
Obrador, G.T.2
Sternberg, M.3
-
52
-
-
30744455082
-
Carnitine treatment improved quality-of-life measure in a sample of midwestern hemodialysis patients
-
Steiber A.L., Davis A.T., Spry L., et al. Carnitine treatment improved quality-of-life measure in a sample of midwestern hemodialysis patients. JPEN J Parenter Enteral Nutr 30 (2006) 10-15
-
(2006)
JPEN J Parenter Enteral Nutr
, vol.30
, pp. 10-15
-
-
Steiber, A.L.1
Davis, A.T.2
Spry, L.3
-
53
-
-
1242342233
-
Serum carnitine concentrations correlated to clinical outcome parameters in chronic hemodialysis patients
-
Steiber A.L., Weatherspoon L.J., Spry L., et al. Serum carnitine concentrations correlated to clinical outcome parameters in chronic hemodialysis patients. Clin Nutr 23 (2004) 27-34
-
(2004)
Clin Nutr
, vol.23
, pp. 27-34
-
-
Steiber, A.L.1
Weatherspoon, L.J.2
Spry, L.3
-
54
-
-
3042648665
-
Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease
-
Vaux E.C., Taylor D.J., Altmann P., et al. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease. Nephron Clin Pract 97 (2004) c41-c48
-
(2004)
Nephron Clin Pract
, vol.97
-
-
Vaux, E.C.1
Taylor, D.J.2
Altmann, P.3
-
55
-
-
0037249525
-
Nutritional effects of carnitine supplementation in hemodialysis patients
-
Chazot C., Blanc C., Hurot J.M., et al. Nutritional effects of carnitine supplementation in hemodialysis patients. Clin Nephrol 59 (2003) 24-30
-
(2003)
Clin Nephrol
, vol.59
, pp. 24-30
-
-
Chazot, C.1
Blanc, C.2
Hurot, J.M.3
-
56
-
-
23844556828
-
Common misconceptions about levocarnitine and dialysis
-
Schreiber B. Common misconceptions about levocarnitine and dialysis. Semin Dial 18 (2005) 349-351
-
(2005)
Semin Dial
, vol.18
, pp. 349-351
-
-
Schreiber, B.1
|